PRC-063 in Adolescent ADHD

NCT02139111 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: Placebo
DRUG: PRC-063 25 mg
DRUG: PRC-063 45 mg
DRUG: PRC-063 70 mg
DRUG: PRC-063 85 mg

Sponsor

Rhodes Pharmaceuticals, L.P.

Collaborators

[object Object]